Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Net Cash Flow (2010 - 2026)

Omeros (OMER) posted Net Cash Flow of -$7.8 million for Q1 2026, down 206.73% sequentially from $7.3 million in Q4 2025, and down 1000.58% YoY from $861000.0 in Q1 2025.

Analysis

Omeros (OMER) Net Cash Flow (2010 - 2026) Analysis & Trends

Omeros has reported Net Cash Flow for 17 years, with the latest figure at -$7.8 million in Q1 2026.

  • Quarterly Net Cash Flow fell 1000.58% year-over-year to -$7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 million (down 196.91% YoY) and the FY2025 annual result came in at $6.3 million, up 268.96% from the prior year.
  • Net Cash Flow retreated to -$7.8 million in Q1 2026 per OMER's latest filing, from $7.3 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $131.4 million in Q3 2022 and troughed at -$134.5 million in Q4 2022.
  • A 5-year average of -$5.8 million and a median of $289000.0 in 2024 frame the typical range for Net Cash Flow.
  • The widest YoY moves for Net Cash Flow: up 2585.28% in 2022, down 6135.23% in 2022.
  • Over 5 years, Net Cash Flow stood at -$134.5 million in 2022, then surged by 82.5% to -$23.5 million in 2023, then soared by 107.98% to $1.9 million in 2024, then jumped by 286.64% to $7.3 million in 2025, then sank by 206.73% to -$7.8 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$7.8 million, $7.3 million, and $491000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 82,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 82,000.00
Mar 31, 2026 -7.75 Mn
Dec 31, 2025 7.31 Mn
Sep 30, 2025 443,000.00
Jun 30, 2025 -2.36 Mn
Mar 31, 2025 861,000.00
Dec 31, 2024 1.88 Mn
Sep 30, 2024 -599,000.00
Jun 30, 2024 289,000.00
Mar 31, 2024 -5.27 Mn
Dec 31, 2023 -23.54 Mn
Sep 30, 2023 24.04 Mn
Jun 30, 2023 2.77 Mn
Mar 31, 2023 -7.18 Mn
Dec 31, 2022 -134.52 Mn
Sep 30, 2022 131.40 Mn
Jun 30, 2022 5.17 Mn
Mar 31, 2022 -91.85 Mn
Dec 31, 2021 93.39 Mn
Sep 30, 2021 -5.29 Mn